Results: 935 news stories
San Antonio Report: ĢƵ lands millions in new state funding
The Washington Post: The science around GLP-1 drugs and cancer is suddenly getting a lot more interesting
Colton Jones, MD, hematology and oncology fellow at UT Health San Antonio, the academic health center of ĢƵ (ĢƵ), was quoted in this article. Read More (subscription required)
Scientific American: Hyperbaric oxygen therapy is being explored as a long COVID treatment. Here’s what the research shows
ĢƵ and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of ĢƵ (CPRIT) to further its mission of combating cancers across South ĢƵ. Since 2010, CPRIT has awarded the newly integrated ĢƵ almost $186 million.
Internist, nephrologist, educator, leader helped shape the school in its early years Marvin Forland, MD, MACP, a founding faculty member of the School of Medicine at what was then The University of ĢƵ Medical School at San Antonio — now the Joe R. and Teresa Lozano Long School of Medicine at UT Health San […]
KENS 5: FDA approves new breast cancer treatments, offering hope for early and late-stage patients
From Classroom to Clinic: Class of 2026 Enters the Next Phase of Training
For the 213 graduates of the Joe R. and Teresa Lozano Long School of Medicine, this year’s commencement signifies more than the culmination of years of rigorous study, clinical training and sacrifice. It marks the beginning of a calling grounded in service, discovery and compassion.
Colton Jones, MD, hematology and oncology fellow at UT Health San Antonio, the academic health center of ĢƵ (ĢƵ), was interviewed for this news segment. Watch Now
KENS 5: UTSA graduates from health programs walk the stage
San Antonio Report: Health Confianza starts new preventive health ‘one-stop shop’ for Bexar County residents
For decades, Alzheimer’s disease research has focused almost exclusively on harmful proteins in the brain. But scientists at ĢƵ are taking a new approach to how the disease is understood and treated.
The human body hosts vast communities of bacteria that influence health in ways scientists are only beginning to fully understand. In recent years, scientists have turned increasing attention to microbiomes as potential contributors to brain health and neurodegenerative disease.
A study published in the Journal of Dental Anesthesia and Pain Medicine explores an emerging approach to delivering local, fast-acting dental anesthesia while reducing the lingering numbness often associated with traditional techniques.
Like a busy restaurant kitchen, our cells depend on well-organized working spaces to assemble the “recipes” that keep the body healthy. ĢƵ scientist, David Libich, PhD, recently received a five-year, $2.1 million Maximizing Investigators’ Research Award from the National Institute of General Medical Sciences to study how certain proteins form these organizational hubs and what happens when things do not go according to plan.
Scientists at ĢƵ (ĢƵ) are investigating a major immune system pathway that leads to the development of chronic pain and a drug that has the potential to stop the process in its tracks. Their study, published April 22 in Cell Reports, is the first of its kind to show a path toward the prevention of chronic pain.
KSAT 12: Hantavirus: San Antonio infectious disease doctor explains rodent-borne illness, symptoms, spread, prevention
When the 1,190 spring and summer graduates of ĢƵ’s six health professional schools walk across commencement stages this weekend, they will begin the next chapter of careers and advanced training dedicated to improving health and well-being. The achievement is the culmination of countless hours spent in laboratories and study rooms, lecture halls and clinical spaces.
For medical student Christopher Mao, the path to medicine didn’t begin in a clinic, but in an engineering lab.
U.S. News & World Report: Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say